期刊文献+

小鼠MIP1-α重组腺病毒载体的构建及其在肝癌细胞中的表达 被引量:3

Construction of adenoviral vector carrying murine MIP1-α and its expression in hepatocellular carcinoma
下载PDF
导出
摘要 目的 :构建小鼠趋化因子 MIP1-α(m MIP1-α)的重组腺病毒载体并在小鼠肝癌细胞中表达 ,为肝癌基因治疗提供实验基础。 方法 :PCR扩增含有 m MIP1-α的质粒 ,将腺病毒骨架质粒 p Ad Easy- 1以及线性化的重组穿梭质粒 p Track- CMV-m MIP1-α共转化 BJ5 183受体菌并在其中发生同源重组 ,利用重组前后抗性的改变筛选出重组子 ,重组腺病毒质粒经过 2 93细胞的包装、扩增和纯化后 ,感染小鼠肝癌细胞株 Hepa1- 6 ,一步法提取细胞总 RNA,RT- PCR检测 m MIP1-α的 m RNA。琼脂糖凝胶打孔法体外观察感染上清中 m MIP1-α对小鼠脾细胞的趋化活性。 结果 :得到了携带 m MIP1-α的重组腺病毒 ,纯化后滴度为 4× 10 1 1 efu/ ml,在感染后的 Hepa1- 6细胞中检测到 m MIP1-α的表达 ,上清中 m MIP1-α的趋化指数为 6 .3。结论 :成功地构建了携带 m MIP1-α的重组腺病毒载体 ,为下一步应用于肝癌的基因治疗提供了基础。 Objective: To construct a recombinant adenoviral vector carrying murine MIP1 α(mMIP1 α) and to express it in hepatocellular carcinoma cell line. Methods: mMIP1 α was amplified from plasmid pBluescript/mMIP1 α, and homologous recombination was performed in BJ5183 bacteria by cotransforming linearized shuttle vector with adenovirus backbone plasmid pAdEasy 1. Recombinant plasmids were screened by alteration of antibiotic. The adenovirus vector was then packaged and amplified in 293 cells. The expression of mMIP1 α in infected murine Hepa1 6 cells was detected by RT PCR. The chemotaxis of mMIP1 α secreted in the supernatants to mouse spleen cells was observed on agarose gel. Results: The recombinant adenoviral vector carrying mMIP1 α was constructed, whose titer was 4×10 11 efu/ml after purification, and the mMIP1 α mRNA was detected in the infected murine Hepa1 6 cells. Bioactive mMIP1 α was detected in the supernatants. Conclusion: The recombinant adenoviral vector carrying mMIP1 α is successfully constructed, paving the way for further application in cancer gene therapy.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2002年第5期494-497,共4页 Academic Journal of Second Military Medical University
基金 上海市卫生系统百名跨世纪优秀学科带头人培养计划基金项目 (3 119975 0 3 0 2 10 40 3 )
关键词 肝肿瘤 MIP1-α 腺病毒载体 细菌同源重组系统 基因治疗 动物实验 liver neoplasms MIP1 α adenovirus vector bacterial homologous recombination system
  • 相关文献

参考文献2

二级参考文献4

  • 1He T C,Proc Nat Acad Sci USA,1998年,95卷,2509页
  • 2Das A M,Clin Exp Immunol,1999年,117卷,2期,223页
  • 3Cook D N,J Immunol,1999年,162卷,9期,5423页
  • 4Luca M,Am J Pathol,1997年,151卷,4期,1105页

共引文献6

同被引文献6

  • 1XiaolingLuo,YizhiYu,AnminLiang,YuanXie,ShuxunLiu,JunGuo,WenyaWang,RunziQi,HuazhangAn,MinghuiZhang,HongmeiXu,ZhenhongGuo,XuetaoCao.Intratumoral Expression of MIP-1β Induces Antitumor Responses in a Pre-Established Tumor Model through Chemoattracting T Cells and NK Cells[J].Cellular & Molecular Immunology,2004,1(3):199-204. 被引量:8
  • 2Wang JM, Deng X, Gong W, et al. Chemokines and their role in tumor growth and metastasis. J Immunol Methods, 1998,220:1-17.
  • 3Nakashima E, Oya A, Kubota Y, et al. A candidate for cancer gene therapy: MIP-1 alpha gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice. Pharm Res, 1996,13: 1896-1901.
  • 4Marshall E, Howell AH, Powles R, et al. Clinical effects of human macrophage inflammatory protein-1 alpha MIP-1 alpha (LD78) administration to humans: a phase I study in cancer patients and normal healthy volunteers with the genetically engineered variant, BB-10010. Eur J Cancer, 1998,34: 1023-1029.
  • 5Qian C, Drozdzik M, Caselmann WH, et al. The potential of gene therapy in the treatment of hepatocellular carcinoma. J Hepatol, 2000,32: 344-351.
  • 6Guo Y, Wu M, Chen H, et al. Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells. Science, 1994,263: 518-520.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部